Vitura Health
- Short interest
- 0.00%
- −0.01 pp 30d
- as of 14 Feb 2025
- Reported shorts
- 5.2K
- Shares on issue
- 656.468M
Vitura Health (VIT) financials
Results, ratios and statements
Latest result
Year to 30 Jun 2026 (FY26) vs FY25, figures in AUD, the reporting currency
- Revenue
- $131.2MM (source: ASX (Markit))vs $124.0M (FY25)
- ASX (Markit), as at 14 Oct 2026
- NPAT
- −$4.4MM (source: ASX (Markit))vs $3.3M (FY25)
- ASX (Markit), as at 14 Oct 2026
- EPS (diluted)
- −$0.007T (source: Derived: trailing 12 months at year end)vs $0.005 (FY25)
- Derived: trailing 12 months at year end, as at 14 Oct 2026
- Rev YoY
- +5.7%FY
- EPS YoY
- n/mTTM
- ASX (Markit)
- Derived: trailing 12 months at year end
Summary of FY2026 Financial Results, 26 Aug 2026
Vitura Health reported FY2026 revenue of $131.2 million, up 5.7% from $124.0 million, but swung to a statutory net loss of $4.4 million versus a $3.1 million profit in FY2025, with normalised NPAT down 97.4% to $0.1 million. No dividend was declared for FY2026, after paying 0.2 cents per share for FY2025. The company expects revenue growth to moderate in FY2027 as it prioritises earnings quality, with early FY2027 results showing significant improvement.
Automated summary of the filing; the filing itself is the record.
Key ratios
Year to 30 Jun 2026 (FY); no balance sheet aligned with this period; prices to 14 Oct 2026
- Gross margin
- 21.7%
- Operating margin
- −1.5%
- Net margin
- −3.3%
- FCF margin
- −1.9%
- ROE
- n/a
- ROA
- n/a
- FCF conversion
- n/a
- Net debt (excl. leases)
- n/a
- Net debt / EBITDA
- n/a
- Current ratio
- n/a
- Interest cover
- −1.2×
- Cash dividends paid / net profit
- n/a
- Market cap
- n/a (no share count we can vouch for)
- P/E
- n/a
- P/B
- n/a (no share count we can vouch for)
Ratios use the reporting currency (AUD); market cap is in AUD. Sources: ASX (Markit) and Derived: trailing 12 months at year end, as at 14 Oct 2026.
Financial statements
Figures in AUD, the reporting currency; Yahoo Finance unless marked
| Line item | FY26 | FY25 | FY24 | FY23 |
|---|---|---|---|---|
| Revenue | $131.2MM (source: ASX (Markit)) | $124.0M | $123.9M | $117.3M |
| Gross profit | $28.4MT (source: Derived: trailing 12 months at year end) | $33.8M | $34.2M | $40.5M |
| Operating income | −$2.0MT (source: Derived: trailing 12 months at year end) | $5.2M | $4.9M | $19.9M |
| EBITDA | −$412.5KT (source: Derived: trailing 12 months at year end) | $7.8M | $7.3M | $21.3M |
| EBIT | −$3.6MT (source: Derived: trailing 12 months at year end) | $5.6M | $5.6M | $20.3M |
| Interest expense | $1.7MT (source: Derived: trailing 12 months at year end) | $856.3K | $1.0M | $225.5K |
| Pretax income | −$5.3MT (source: Derived: trailing 12 months at year end) | $4.7M | $4.6M | $20.1M |
| Tax | −$887.6KT (source: Derived: trailing 12 months at year end) | $1.6M | $1.3M | $6.3M |
| NPAT | −$4.4MM (source: ASX (Markit)) | $3.3M | $3.5M | $13.8M |
| Net interest income | −$1.4MT (source: Derived: trailing 12 months at year end) | −$820.1K | −$377.5K | $108.8K |
| EPS basic | −$0.007T (source: Derived: trailing 12 months at year end) | $0.005 | $0.006 | $0.025 |
| EPS diluted | −$0.007T (source: Derived: trailing 12 months at year end) | $0.005 | $0.006 | $0.024 |
| Shares | n/a | 662.3M | 575.9M | 556.5M |
- ASX (Markit)
- Derived: trailing 12 months at year end
Financial reports
The company's own filings, newest first
- FY2026 Financial ResultsFinancial Report26 Aug 2026via asx_announcements
- ASX Appendix 4E Preliminary Final ReportAnnual Results26 Aug 2026via asx_announcements
- H1 FY26 Appendix 4D and Half Year ReportHalf Year Results25 Feb 2026via asx_announcements
- 2025 Annual ReportAnnual Report22 Oct 2025via asx_announcements
- FY2025 Financial ResultsFinancial Report25 Aug 2025via asx_announcements
- ASX Appendix 4E Preliminary Final ReportAnnual Results25 Aug 2025via asx_announcements
- Appendix 4DHalf Year Results26 Feb 2025via asx_announcements
- 2025 Half-Year Financial ReportHalf Year Results26 Feb 2025via asx_announcements
- H1 FY2025 financial resultsFinancial Report26 Feb 2025via asx_announcements
- 2024 Annual ReportAnnual Report23 Oct 2024via asx_announcements
Showing 10 of 14 reports